Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Chongqing Zhifei
ISIN CNE100000V20
|WKN A111BN
Market cap (in EUR)
3,708 m
Country
China
Sector
Healthcare
Dividend yield
8.32%
Overview
Description
Chongqing Zhifei Biological Products Co., Ltd. engages in the wholesale of biological products and vaccines. Its products include meningococcal group A&C conjugate vaccine, meningococcal polysaccharide vaccine, mycobacterium vaccine, haemophilus influenzae type b conjugate vaccine, and freeze-dried live attenuated hepatitis A vaccine. It also engages in the biotechnology research, development, consulting, storage, and import and export services. The company was founded in 2002 and is headquartered in Chongqing, China.
Healthcare Healthcare Services Healthcare Support Services China
Financials
Key metrics
| Market capitalisation, EUR | 3,708 m |
| EPS, EUR | -0.75 |
| P/B ratio | 1.9 |
| P/E ratio | 216.3 |
| Dividend yield | 8.32% |
Income statement (2025)
| Revenue, EUR | 1,100 m |
| Net income, EUR | -1,816 m |
| Profit margin | -165.01% |
What ETF is Chongqing Zhifei in?
There are 23 ETFs which contain Chongqing Zhifei. All of these ETFs are listed in the table below. The ETF with the largest weighting of Chongqing Zhifei is the Xtrackers Harvest CSI 300 UCITS ETF 1D.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.